(S)-UFR2709  

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:10mg in glass bottle
产品描述:基本信息 产品编号: U10112 产品名称: (S)-UFR2709 CAS: 1431628-22-6   储存条件 粉末 -20℃ 四年 分子式: C13H17NO2 溶于液体 -80℃ 一年 分子量: 219.28     化学名:  Benzoic acid [(2S)-1-methylpyrrolidine-2-yl]methyl ester Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   生物活性 产品描述 一种竞争性的nAChR拮抗剂,并显示出较强的亲和力,对α4β2 nAChR的亲和力比对α7 nAChR的高。(S)-UFR2709在偏好酒精的老鼠中减少焦虑,并且可以减少其酒精摄入和对酒精偏好。(S)-UFR2709是抗焦虑试剂,可用于研究尼古丁成瘾。 靶点 nAChR   体外研究 Brain nicotinic acetylcholine receptors (nAChRs) is a heterogeneous family of pentameric acetylcholine-gated cation channels,which is a molecular target for the treatment of alcohol abuse and dependence. 体内研究 (S)-UFR2709 (50-100μg/ml;3 min and then maintained for another 5 min in a holding tank before testing the swimming behaviour in the test tank for a period of 5 min) produces a decrease in the bottom dwelling for NTT test,and UFR2709 induces a significant and dose-dependent decrease in bottom dwelling time to 52.9 and 87.0 s,respectively at 50 and 100μg/ml.(S)-UFR2709 (50-100μg/ml) decreases nicotine-evoked mRNA expression of α4 nACh receptor subunit,but UFR2709 has less effect on α4 nACh receptor subunit in the brain of adult zebrafish.(S)-UFR2709 (intraperitoneal injection;1-10mg/kg;daily;17 days) reduces ethanol consumption and ethanol preference and increased water consumption in a dose-dependent manner.The most effective dose of UFR2709 is 2.5mg/kg,it induces a 56% reduction in alcohol consumption.(S)-UFR2709 does not affect the weight or locomotor activity of the rats. Animal Model: High-alcohol-drinking UChB rats Dosage: 10mg/kg,5mg/kg,2.5mg/kg,or 1mg/kg Administration: Intraperitoneal injection;1-10mg/kg;daily;17 days Result: Did not affect the weight or locomotor activity and reduced ethanol consumption and preference.
保存条件:-20℃